A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1

Thorax

Volumn 55, Issue 8, 2000, Pages 685-690

  Wallace, G M F ^a   Shovlin, C L ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Genetic linkage; Pulmonary arteriovenous malformations; Transforming growth factor

Indexed keywords

ENDOGLIN; OLIGONUCLEOTIDE; PHOSPHORUS 32; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; DNA DETERMINATION; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; MALE; PEDIGREE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; PRIORITY JOURNAL; PULMONARY ARTERY MALFORMATION; PULMONARY VEIN MALFORMATION; RENDU OSLER WEBER DISEASE; SCHOOL CHILD; SIGNAL TRANSDUCTION; TANDEM REPEAT; VASCULAR ENDOTHELIUM;

ACTIVIN RECEPTORS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CHILD; DYSTONIC DISORDERS; FEMALE; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033910409     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.8.685     Document Type: Article

References (43)

1. 1 White RI, Mitchell SE, Earth KH, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. AJR 1983;140:681-6.
2. 2 Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-29.
3. 3 Dines DE, Arms RA, Bernatz PE, et al. Pulmonary arteriovenous fistulas. Maya Clin Proc 1974;49:460-5.
4. 4 Sluiter-Eringa H, Orie NGM, Sluiter HJ. Pulmonary arteriovenous fistula. Diagnosis and prognosis in noncomplainant patients. Am Rev Respir Dis 1969;100:177-88.
5. 5 Stringer C, Stanley A, Bates R, et al. Pulmonary arteriovenous fistula. Am J Surg 1955;89:1054-80.
6. 6 Yater W, Finnegan J, Giffin H. Pulmonary arteriovenous fistula (varix). JAMA 1949;141:581-9.
7. 7 Hughes JMB, Allison DJ. Pulmonary arteriovenous malformations: the radiologist replaces the surgeon. Clin Radiol 1990;41:297-8.
8. 8 Saluja S, Sitko I, Lee DW, et al. Embolotherapy of pulmonary arteriovenous malformations with detachable balloons: long term durability and efficacy. J Vasc Intervent Radiol 1999;10:883-9.
9. 9 Plauchu H, de Chadarévian J-P, Bideau A, et al Age-related profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Gener 1989;32:291-7.
10. 10 Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
11. 11 Haitjema T, Westermann CJJ, Overtoom TTC, et al. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1996;156:714-9.
12. 12 Thompson RD, Jackson JE, Peters AM, et al. Sensitivity and specificity of radioisotope right-left shunt measurements and pulse oximetry for the early detection of pulmonary arteriovenous malformations. Chest 1999;115:109-13.
13. 13 Kjeldsen AD, Oxhøj H, Andersen PE, et al. Pulmonary arteriovenous malformations: Screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999;116:432-9.
14. 14 Shovlin CL, Hughes JMB, Tuddenham EGD, et al. A gene for hereditary haemorrhagic telangíectasía maps to chromosome 9q3. Nat Gene: 1994;6:205-9.
15. 15 McDonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nature Genet 1994;6:197-204.
16. 16 McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet 1994;8:345-51.
17. 17 Vincent P, Plauchu H, Hazan J, et al. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995;4:945-9.
18. 18 Johnson DW, Berg JN, Gallione CJ, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 1995;5:21-8.
19. 19 Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genet 1996;13:189-95.
20. 20 Piantanida M, Buscarini E, Dellavecchia C, et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 1996;33:441-3.
21. 21 Heldin C-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-71.
22. 22 Pece BN, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 1999;274:584-94.
23. 23 McAllister KA, Baldwin MA, Thukkani AK, et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type I suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995;4:1983-5.
24. 24 Shovlin CL, Hughes JMB, Scott J, et al. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997;61:68 79.
25. 25 Pece-Barbara N, Vera S, Cymerman U, et al. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 1997;100:2568-79.
26. 26 Yamaguchi H, Azuma H, Shigeyiho T, et al. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemost 1997;77:243-7.
27. 27 Gallione C, Klaus D, Yeh E, et al. Mutation and expression analysis of the endoglin gene in hereditary haemorrhagic telangiectasia. Hum Mutat 1998;11:286-94.
28. 28 Pece-Barbara N, Cymerman U, Vera S, et al. Expression analysis of four endoglin missense mutations suggests haplo-insuffidency is the predominant mechanism for hereditary hemorrhagic telangiectasia type I. Hum Mol Genet 1999;8: 2171-81.
29. 29 Cymerman U, Vera S, Pece-Barbara N, et al. Identification of hereditary hemorrhagic telangiectasia type I in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 2000;47:24-35.
30. 30 Berg JN, Gallione C, Stenzel T, et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary haemorrhagic telangiectasia. Am J Hum Genet 1997;61:60-7.
31. 31 Klaus D, Gallione C, Anthony K, et al. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary haemorrhagic telangiectasia. Human Mutation, Mutations in Brief Online 1998;#164.
32. 32 Berg JN, Guttmacher AE, Marchuk DA, et al. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7.
33. 33 Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
34. 34 Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. 2nd edn. Cold Spring Harbor Laboratory Press, 1989.
35. 35 Gyapar G, Morisette J, Vignal A, et al. The 1993-94 Généthon human genetic linkage map. Nature Genet 1994;7: 246-339.
36. 36 GenBank. National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/ 1999.
37. 37 Ott J. Analysis of human genetic linkage. 2nd edn. Baltimore: The Johns Hopkins University Press, 1992.
38. 38 Shovlin CL, Winstock AR, Peters AM, et al. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Q J Med 1995;88:879-87.
39. 39 Hughes JMB, Shovlin CL, Simonds AK. Pulmonary disease and cor pulmonale. In: Oakley C, ed. Heart disease in pregnancy. London: BMJ Publishing Group, 1997: 180-200.
40. 40 Lux A, Attisano L, Marchuk D. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 1999;274:9984-92.
41. 41 Letamandia A, Lastres P, Botella L, et al. Role of endoglin in cellular responses to transforming growth factor-β. J Biol Chem 1998;273:33011-9.
42. 42 Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999; 104:1343-51.
43. 43 Shovlin C. Supermodels and disease: insights from the HHT mice. J Clin Invest 1999;104:1335-6.